Follow The Filings

GTBP GT Biopharma

GT Biopharma earnings company data as of 4:48 AM ET 10/23

  • 0 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS -0.08 -0.12 Miss
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
424B3
DEF 14A
S-1
8-K 8.01,9.01
8-K 1.01,3.02,3.03,5.03,9.01
SCHEDULE 13G —
8-K 1.01,3.02,3.03,5.03,9.01
8-K 3.03,5.03,8.01,9.01
10-Q
8-K 5.07,9.01
DEF 14A
8-K 5.03,9.01
8-K 3.01,9.01
10-Q
424B3
S-1
8-K 1.01,9.01
10-Q/A
10-Q/A
8-K 4.02,9.01
10-K
424B3
S-1
424B3
424B3

Insider forms

Forms 3, 4 and 5 from EDGAR, 1 row shown

Filed Form Detail Links
4 Period Sep 4, 2025 (5 forms)

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.